Inventor · disambiguated record

Taleen G. Hanania

Also filed as: HANANIA TALEEN G

15 granted patents·9 pending applications·77 citations·filing 2010–2024

92Inventor score

Technology areasA61P C07D A61K

Files withSUNOVION PHARMACEUTICALS INC19 SUMITOMO PHARMA AMERICA INC3 PGI DRUG DISCOVERY LLC1 SHAO LIMING1

Top patents by PatentIndex Score

24 records

0195US10894033B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·3 cites·21 claims
0295US8710245B2Multicyclic compounds and methods of use thereofSHAO LIMING·Filed 2010·Granted Apr 29, 2014·32 cites·41 claims
0391US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
0491US10085968B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·7 cites·60 claims
0591US9351954B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·10 cites·37 claims
0689US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
0785US2024358675A1Multicyclic compounds and methods of use thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
0881US10556890B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 11, 2020·2 cites·14 claims
0981US9758529B2Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·3 cites·54 claims
1081US2024409550A1Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
1180US2022387382A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
1279US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
1375US10189825B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Jan 29, 2019·2 cites·25 claims
1475US2021267938A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
1573US10927124B2Compounds and compositions and uses thereofPGI DRUG DISCOVERY LLC·Filed 2018·Granted Feb 23, 2021·1 cites·26 claims
1673US2022185799A11-heterocyclyl isochromanyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
1770US11958862B2Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2021·Granted Apr 16, 2024·0 cites·34 claims
1870US11332462B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted May 17, 2022·0 cites·15 claims
1969US11192885B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Dec 7, 2021·0 cites·24 claims
2069US2021300942A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
2168US2019125722A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
2261US2020024286A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
2356US2018057506A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
2453US11077090B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Aug 3, 2021·0 cites·45 claims

Join the waitlist — get patent alerts

Get an alert when Taleen G. Hanania files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →